Provides coverage for a cranial prosthesis under certain conditions; defines a cranial prosthesis as a wig or hairpiece.
Summary
This bill, titled the “wig insurance guarantee (W.I.G) act,” requires certain New York health insurance policies and contracts that already cover prostheses to also cover cranial prostheses for people experiencing permanent or temporary medical hair loss. The bill defines a cranial prosthesis as a wig or hairpiece and applies the requirement to individual policies, group or blanket policies, and certain hospital service, health service, and medical expense indemnity coverage.
Coverage would be available only when a licensed provider prescribes the wig or hairpiece as part of treatment for a diagnosed health condition, chronic illness, or injury. The bill specifically references conditions such as alopecia areata, alopecia medicamentosa, scarring alopecia, and lupus, but the list is not exclusive. Insurers could limit coverage to once every 12 months, cap payment at $750 per instance, and apply otherwise applicable cost-sharing requirements.
Impact
The bill would amend sections 3216, 3221, and 4303 of the New York Insurance Law to create an explicit coverage mandate for cranial prostheses in policies that cover prostheses. It would require affected insurers and health plans to treat medically necessary wigs and hairpieces as covered prosthetic items, subject to the bill’s frequency, dollar cap, and cost-sharing limits. The mandate would apply to policies and contracts issued, delivered, renewed, or modified on or after the effective date, which is immediate upon enactment.
Sentiment
The available context suggests generally supportive intent, with the bill advancing through committee and being amended and recommitted rather than rejected. Although there are no recorded votes or transcripts provided, the bill’s framing as a coverage guarantee for medically necessary hair loss treatment indicates a consumer- and patient-protection approach. The absence of recorded opposition in the supplied materials limits any stronger conclusion about divided sentiment.
Contention
The main policy questions likely concern cost and scope: insurers may object to the new mandated benefit, the $750 cap, and the requirement to cover wigs or hairpieces when prescribed for medical hair loss. Another possible point of contention is the breadth of qualifying conditions, since the bill covers not only named diagnoses like alopecia and lupus but also other health conditions, chronic illnesses, or injuries that cause hair loss. Supporters would likely emphasize access and affordability for patients facing medically induced hair loss, while opponents may focus on premium impact and administrative burden.